Literature DB >> 7026174

Saturable metabolism and its relationship to toxicity.

M E Andersen.   

Abstract

Metabolism plays a central role in regulating the toxicity of a variety of chemicals. Relatively innocuous substances can be converted to highly toxic metabolites. Conversely, toxic substances can be biotransformed to less harmful metabolites or be excreted, thus limiting their duration of biological action. Virtually all metabolism and many excretory processes utilize specific binding proteins, i.e., enzymes and carrier proteins. These metabolic and carrier-mediated excretory clearance pathways are capacity-limited, becoming saturated at sufficiently high substrate concentrations. Saturable metabolic clearance processes lead to dose-dependent pharmacokinetics for many chemicals. When dose-dependent pharmacokinetics prevail, internally significant parameters, such as area under the curve for concentration of toxicant at active sites and the amount of metabolite formed during inhalation exposure, are not linearly related to externally significant parameters such as administered dose or inspired concentration. Dose-response curves should relate observed effects to some internally significant parameter. Toxic response should often be indexed to area under the curve relationships or total amount metabolized, instead of dose or inspired concentration. The former parameters are complexly related to the latter. The nature of the relationship depends on the kinetic constants for metabolic and excretory clearance. Pharmacokinetic analyses of dose-dependent clearance mechanisms provide an understanding of how one transforms externally significant parameters to internally significant parameters under various exposure conditions. Consideration of metabolic clearance at the organ level illuminates the importance of physiological factors, showing unequivocally that blood flow may be rate-limiting for metabolism under many exposure conditions. Recognition of the potential for this behavior is essential to the proper design and evaluation of certain toxicological experimentation. Development of comprehensive pharmacokinetic descriptions of the influence of saturable clearance on delivery of active chemical to target sites augurs well for improving both intraspecies and interspecies extrapolation of toxicity data. This is a critical area of contemporary toxicology. Dose selection for chronic studies could also be improved by knowledge of the dose-dependence of pharmacokinetic parameters in proposed test species. The field of toxicology reviewed here represents an interface between pharmacokinetic research and studies on basic mechanisms of toxic action. It entails utilization of quantitative concepts to better understand the physiological and biochemical controls which regulate the expression of the toxicity of various chemicals. Much work remains to be accomplished in this exciting area of toxicological research. Some of the predictions of the pharmacokinetic analyses are still tentative and require more definitive experimentation...

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026174     DOI: 10.3109/10408448109059563

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  15 in total

1.  The impact of saturable metabolism on exposure-response relations in 2 studies of benzene-induced leukemia.

Authors:  Jelle Vlaanderen; Lützen Portengen; Stephen M Rappaport; Deborah C Glass; Hans Kromhout; Roel Vermeulen
Journal:  Am J Epidemiol       Date:  2011-07-10       Impact factor: 4.897

2.  Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man.

Authors:  A Koizumi
Journal:  Br J Ind Med       Date:  1989-04

3.  Biological considerations in assessing exposures to genotoxic and carcinogenic agents.

Authors:  S M Rappaport
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Uptake, distribution, metabolism, and elimination of styrene in man. A comparison between single exposure and co-exposure with acetone.

Authors:  E Wigaeus; A Löf; M B Nordqvist
Journal:  Br J Ind Med       Date:  1984-11

Review 5.  Low-dose metabolism of benzene in humans: science and obfuscation.

Authors:  Stephen M Rappaport; Sungkyoon Kim; Reuben Thomas; Brent A Johnson; Frederic Y Bois; Lawrence L Kupper
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

6.  Metabolic changes following oral exposure to tetrachloroethylene in subtoxic concentrations.

Authors:  E Marth
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

7.  Quantitative evaluation of ethane and n-pentane as indicators of lipid peroxidation in vivo.

Authors:  J G Filser; H M Bolt; H Muliawan; H Kappus
Journal:  Arch Toxicol       Date:  1983-02       Impact factor: 5.153

8.  A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations.

Authors:  M J Angelo; K B Bischoff; A B Pritchard; M A Presser
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

9.  Tissue dosimetry, physiologically-based pharmacokinetic modeling, and cancer risk assessment.

Authors:  M E Andersen
Journal:  Cell Biol Toxicol       Date:  1989-12       Impact factor: 6.691

10.  Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats.

Authors:  H M Bolt; J G Filser; F Störmer
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.